A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform
The Pharmacogenomics Journal2009Vol. 10(3), pp. 191–199
Citations Over TimeTop 10% of 2009 papers
John F. Deeken, Tom Cormier, Douglas K. Price, Tristan M. Sissung, Seth M. Steinberg, Khanh Bao Tran, David J. Liewehr, William L. Dahut, Xin Miao, William D. Figg
Related Papers
- Docetaxel (Taxotere): preclinical and general clinical information.(1999)
- → The plinabulin/docetaxel combination to mitigate the known safety concerns of docetaxel.(2016)3 cited
- → Docetaxel (Taxotere) in the Treatment of Non-Small Cell Lung Cancer(2002)18 cited
- → Thalidomide, semen distribution, teratogenicity… and cost: reply from authors(2006)
- TS-1 による術後補助療法中に発症しWeekly Docetaxel 療法により著効をみた胃癌腹膜播種の1 例(2005)